Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • IGF-1R
    (2)
  • DNA-PK
    (1)
  • PI3K
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Endocrine system
    (1)
Filter
Search Result
Results for "

ophthalmopathy

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
PI3K-IN-1
XL765, Voxtalisib Analogue, SAR245409
T18261349796-36-6
PI3K-IN-1 (Voxtalisib Analogue) is a dual inhibitor of mTOR/PI3K, mostly for p110γ , also inhibits DNA-PK and mTOR.
  • $30
In Stock
Size
QTY
Veligrotug
AVE1642, AVE 1642
T808712728655-31-8
Veligrotug is an intravenously administered anti-insulin-like growth factor-1 receptor antibody developed for the treatment of thyroid eye disease (TED). Veligrotug has demonstrated rapid reductions in diplopia as well as improvements in orbital inflammation, thereby highlighting its potential as a targeted biologic research tool in autoimmune ophthalmopathy.
  • $247
In Stock
Size
QTY
VRDN-002
T9901A-1653
VRDN-002 is a humanized monoclonal antibody (mAb) targeting IGF1R/CD221. It is designed to reduce inflammation and exophthalmos associated with thyroid eye disease (TED). Additionally, VPI-2690B is utilized in research related to Graves' ophthalmopathy.
  • Inquiry Price
Inquiry
Size
QTY